Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith D Robertson

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
BMC Genomics|April 4, 2023
Titration-based normalization of antibody amount improves consistency of ChIP-seq experimentsAriel Caride, Jin Sung Jang, Geng-Xian Shi, et al.
Clinical Epigenetics|April 29, 2023
Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcomeLouis Y El Khoury, Xiaoyu Pan, Ryan A Hlady, et al.
Drug and Alcohol Dependence|February 16, 2024
DNA methylation at DLGAP2 and risk for relapse in alcohol dependence during acamprosate treatmentFatih Özel, Michela Di Criscio, Diana Ioana Lupu, et al.
Nucleic Acids Research|July 26, 2011
Targeted bisulfite sequencing by solution hybrid selection and massively parallel sequencingEun-Joon Lee, Lirong Pei, Gyan Srivastava, et al.
Molecular Oncology|July 7, 2023
SETD2 loss in renal epithelial cells drives epithelial-to-mesenchymal transition in a TGF-β-independent mannerTianchu Wang, Ryan T Wagner, Ryan A Hlady, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Histone Modifications and miRNA Perturbations Contribute to Transcriptional Dysregulation of Hypertrophy in Obstructive Hypertrophic CardiomyopathyRamin Garmany, Surendra Dasari, J Martijn Bos, et al.
JCI Insight|June 28, 2022
SHP2 inhibition enhances Yes-associated protein-mediated liver regeneration in murine partial hepatectomy modelsRyan D Watkins, EeeLN H Buckarma, Jennifer L Tomlinson, et al.
Genome Biology|February 5, 2025
SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylationRyan T Wagner, Ryan A Hlady, Xiaoyu Pan, et al.
Clinical Epigenetics|January 19, 2021
Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancerLouis Y El Khoury, Shuang Fu, Ryan A Hlady, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 9, 2008
Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomasJingxin Qiu, Lingbao Ai, Cheppail Ramachandran, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
BMC Genomics|April 4, 2023
Titration-based normalization of antibody amount improves consistency of ChIP-seq experimentsAriel Caride, Jin Sung Jang, Geng-Xian Shi, et al.
Clinical Epigenetics|April 29, 2023
Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcomeLouis Y El Khoury, Xiaoyu Pan, Ryan A Hlady, et al.
Drug and Alcohol Dependence|February 16, 2024
DNA methylation at DLGAP2 and risk for relapse in alcohol dependence during acamprosate treatmentFatih Özel, Michela Di Criscio, Diana Ioana Lupu, et al.
Nucleic Acids Research|July 26, 2011
Targeted bisulfite sequencing by solution hybrid selection and massively parallel sequencingEun-Joon Lee, Lirong Pei, Gyan Srivastava, et al.
Molecular Oncology|July 7, 2023
SETD2 loss in renal epithelial cells drives epithelial-to-mesenchymal transition in a TGF-β-independent mannerTianchu Wang, Ryan T Wagner, Ryan A Hlady, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Histone Modifications and miRNA Perturbations Contribute to Transcriptional Dysregulation of Hypertrophy in Obstructive Hypertrophic CardiomyopathyRamin Garmany, Surendra Dasari, J Martijn Bos, et al.
JCI Insight|June 28, 2022
SHP2 inhibition enhances Yes-associated protein-mediated liver regeneration in murine partial hepatectomy modelsRyan D Watkins, EeeLN H Buckarma, Jennifer L Tomlinson, et al.
Genome Biology|February 5, 2025
SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylationRyan T Wagner, Ryan A Hlady, Xiaoyu Pan, et al.
Clinical Epigenetics|January 19, 2021
Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancerLouis Y El Khoury, Shuang Fu, Ryan A Hlady, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 9, 2008
Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomasJingxin Qiu, Lingbao Ai, Cheppail Ramachandran, et al.
Pageof 10